HHT downregulated TMEM16A expression in a dose-dependent manner in lung cancer LA795 cell lines, which in turn reduced the phosphorylation of MEK1/2 and ERK1/2 in the MAPK pathway, affecting tumor cell proliferation, invasion, and cell cycle (78). This evidence concerns the gene ANO1 and neoplasm.